Enovis (ENOV) Notes Payables (2015 - 2016)
Enovis' (ENOV) quarterly Notes Payables came in at $151.0 million in Q4 2016, down 22.57% year-on-year from $195.0 million in Q1 2016, and down 22.57% on a QoQ basis from $195.0 million in Q4 2015.
Enovis (ENOV) Notes Payables (2015 - 2016) Analysis & Trends
Enovis (ENOV) has 2 years of Notes Payables data on file, last reported at $151.0 million in Q4 2016.
- On a quarterly basis, Notes Payables fell 22.57% year-over-year to $151.0 million in Q4 2016; TTM through Dec 2016 was $151.0 million, a 22.57% decrease from a year earlier, with the FY2016 full-year figure at $151.0 million, down 22.57% from the prior year.
- Notes Payables for Q4 2016 stood at $151.0 million, down from $195.0 million in the prior quarter.
- Over the last five years, Notes Payables for ENOV reached as high as $195.0 million in Q4 2015 and fell as low as $151.0 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn |
| 10 | Enovis | 1.59 Bn | 1.56 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 151.02 Mn |
| Dec 31, 2015 | 195.04 Mn |